Aoxing Pharmaceutical appoints CFO

WORKFLOW SOLUTIONS
PRODUCTS
See More S&P Global Solutions
CONTENT
SECTOR-SPECIFIC INSIGHTS
More ways we can help
NEWS & RESEARCH TOPICS
See More
Featured Events
WebinarM&A In Focus: Tech Acquisitions and the ‘New Normal’ in 2023
- 02/08/2023
- Live, Online
- 11:00 am - 12:00 pm EST
Webinar ReplaysAssessing the impact of the U.S. Government Accountability Office recommendations’ on Export Control Compliance at universities
- 01/18/2023
- On-Demand
- 60 minutes
ConferenceTPMTech
- 02/23/2023
- Hilton Long Beach Convention Center
PLATFORMS
OTHER PRODUCTS
- Research Online
- 451 Research
See All Product Logins

In This List

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

4 Aug, 2017 | 18:52

Author Mirza Salam Ahmed
Theme Healthcare & Pharmaceuticals

Aoxing Pharmaceutical Co. Inc. appointed Guoan Zhang to the position of CFO.

Zhang replaces Zheng Chen, who has resigned as CFO.

Zhang has been the company's senior vice president of finance since June 2010 and chief accounting officer since March 2010. He has also served as Aoxing's acting CFO from July 2012 to December 2014 and Nov. 30, 2015, to Jan. 27, 2016.